Frutarom Continues to Implement its Rapid Growt... (ragrance pharmaceutical nutraceuticalhea...)

Frutarom Continues to Implement its Rapid Growth Strategy

Date:11/20/2008

ragrance, pharmaceutical, nutraceutical, health food, functional food, food additive, and cosmetic industries.

Frutarom, which employs approximately 1,500 people worldwide, operates through two Divisions:

    - The Flavors Division, which develops, produces and markets
      flavor compounds and food systems.

    - The Fine Ingredients Division, which develops, produces and
      markets natural flavor extracts, natural functional food ingredients,
      natural pharma/nutraceutical extracts, specialty essential oils and
      citrus products, and aroma chemicals.

Frutarom's products are produced at its plants in the United States, England, Switzerland, Germany, Israel, China, and Turkey. The Company's global marketing organization includes branches in Israel, the United States, England, Switzerland, Germany, Belgium, Holland, Denmark, France, Hungary, Romania, Russia, Ukraine, Kazakhstan, Belarus, Turkey, Brazil, Mexico, China, Japan, Hong Kong, India and Indonesia. The Company also works through local agents and distributors worldwide.

    For further information, visit our website:http://www.frutarom.com

    Company Contact
    Ori Yehudai, President & CEO
    Frutarom Ltd.
    Tel: +972-9960-3800
    Email: oyehudai@frutarom.com

SOURCE Frutarom Industries Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors
2. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
3. Salmonella Outbreak Tied to Dry Dog Food Continues
4. International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis
5. AlphaDetail, Inc. Continues Bi-coastal Expansion
6. Psychiatric Congress Focus on Depressive Disorders Continues Through the Weekend
7. International Medical Corps Continues Delivering Emergency Relief Amid Violence in Democratic Republic of Congo
8. The Wellness(R) Core(R) Family Continues to Grow With New Higher Protein, Grain-Free Canned Varieties for Cats and Dogs
9. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
10. Quadriplegic Man Defied the Odds, Continues to Inspire
11. The RightThing Continues Drive: Completes Strong Q3

Post Your Comments:

(Date:11/9/2009)...l Nutrition announced today the acquisition of App...ed subsidiary of Natural Nutrition. Natural Nutri... the company will focus its efforts on the busines...oping mobile application market places throughout ...sed on multi platform apps designed to run on devi...

(Date:11/9/2009)...-Asia/ -- Simcere Pharmaceutical Group,(NYSE: SCR...eutical company,specializing in the development, m... proprietary pharmaceuticals in China, today annou...ense in China of Rosuvastatin from Tianjin,Tianda ...on of the,manufacturing license will be effected t...

(Date:11/9/2009)...eer development of scientists and science trainees...inical medicine, AAAS, Science Careers, and Scienc...e called CTSciNet, the Clinical and Translational ...B) November 6, 2009 -- Launched October 20 by Scie... CTSciNet is an online community for people purs...

(Date:11/9/2009)... now available in New York City by pain management...Y (PRWEB) November 9, 2009 -- Davis Bregman , a p...ouse calls to residents of Manhattan in New York C...l by calling the office at 212-918-1629 or sendin...e of being able to see the doctor in the less stre...

(Date:11/9/2009)...form Bill, The Affordable Health Care for American...aturday Night, and Is Expected to Be Signed into L...ith Absolute Confidence. ERISAclaim.com Announced ...cifically for the Compliance with the New Federal ... Hanover Park, IL (PRWEB) November 9, ...

Breaking Medicine News(10 mins):Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2 Health News:Social Network for Translational Scientists Launched 2 Health News:Social Network for Translational Scientists Launched 3 Health News:Social Network for Translational Scientists Launched 4 Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2 Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2 Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3 Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4 Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5

[0] Natural Nutrition Acquires App Tech Global, Inc.[0] Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin [0] Social Network for Translational Scientists Launched [0] Davis Bregman MD Now Offering House Calls in Manhattan [0] The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com

...lecular Corporation, a,pioneer in the development ...lysis systems, announced today that Fran Tuttle ha.... Tuttle is president and chief executive,officer ...ard," said Xceed,s President and,CEO, David Deems....

...as released,today by the U.S. Department of Justic...m Ronald Tenpas, acting Assistant Attorney,General...n here at the,Department of Justice. Joining me to...nmental enforcement,settlement in the history of o...

...use study shows , TUESDAY, Oct. 9 (HealthDay News)...that may lead to a treatment for the hereditary, p...on,s disease (HD). , In mice, a molecule called C2... Disorders (MIND), Boston. Their study appears in ...

...finds , , TUESDAY, Oct. 9 (HealthDay News)...dren who,ve lost weight keep it off, new research ... effect of the maintenance programs wears off over...tudy. Clearly, maintenance treatment was better th...

...ose in commercial managed-care plans, study says ,...icaid enrollees receive lower quality health care ...tients in commercial health plans, a new study fou...nts. , "The policy message is that to the extent t...

...eveloped a potentially novel way to fight colorect...arrages of radiation inside cancer cells, unlike c...s and attack from the outside and cause unwanted s... cells, and whats left over is likely to be easily...

Xceed Molecular Names Fran Tuttle to Its Board of Trustees Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power Molecule Promising Against Huntington's Disease Maintenance Treatment Helps Kids Keep Weight Off Medicaid Managed Care Seems to Fall Short Inside job: new radioactive agents for colon cancer work inside cells

(Date:11/6/2009)..., Nov. 6 NuVasive, Inc. ... on developing products for minimally disruptive s...the appointment of Michael J. Lambert as Executive...tive November 9, 2009. The Company also announced...,, "Michael will be an excellent complement to ...

(Date:11/6/2009)... Manitoba, Nov. 6 With his propose...has set his sights on cutting name-brand prescript... who fall into the "Part D" coverage gap, universa... about the potential cost-cutting and feel it,s a ... the most powerful lobbyists want a revised progra...

(Date:11/6/2009)...Nov. 6 Cyberonics, Inc. ...will report financial results for the second quart...g April 30, 2010 on Wednesday, November 18, 2009 a...nce call to discuss those results on Thursday, Nov... 2010 Second Quarter Results Conference Call Instr...

[0] NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates [0] Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole'[0] Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results

...tors to Better Target Patients for ALIMTA(R), (pem...ll Cell Lung Cancer, BARCELONA, Spain, Sept. 25 ...mall cell lung cancer (NSCLC) that,are classified ...ically,significant higher survival when treated in...d for injection) when compared to,histologically-s...

... (DSMB) Authorizes Enrollment of Cervical ...el, HOPKINTON, Mass., Sept. 24 Alseres,Pharmaceu...ndependent Data,Safety Monitoring Board (DSMB) has...ase I/IIa clinical trial in acute spinal cord inju... treated with a 9 mg dose of,Cethrin(R). This reco...

Other Medicine Technology:Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 2 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 3 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 4 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 5 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 6 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 7 Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 8 Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 2 Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 3 Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 4 Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 5

Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial

...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...

Medicine Products:

Glucose, Body Fluid Glucagon Glomerular Basement Membrane Antibody, IgA (IFA)Gliadin Peptide Antibodies, IgA & IgG

Frutarom Continues to Implement its Rapid Growt...(ragrance pharmaceutical nutraceuticalhea...),Health